by Anthony Montanarella | Sep 20, 2024 | Company News, News, Product News
Horseheads, New York – August 26, 2024XGen Pharmaceuticals DJB, Inc. (XGen), a leading manufacturer in the generics pharmaceutical industry, is proud to announce that it has achieved full compliance with the Drug Supply Chain Security Act (DSCSA) well ahead of the...
by support@incommandtech.com | Feb 14, 2024 | Company News, Product News
Cyclophosphamide for Injection, USP XGen Pharmaceuticals DJB, Inc. is pleased to announce the addition of Cyclophosphamide for Injection, USP to their expanding product line. Cyclophosphamide for Injection will be available with a 3 year shelf-life in single-dose...
by support@incommandtech.com | Jul 5, 2023 | Company News, Product News
Pentamidine Isethionate for Injection and Pentamidine Isethionate for Inhalation XGen Pharmaceuticals DJB, Inc. is pleased to announce U.S. Food and Drug Administration (USFDA) approval for two new additions to their expanding product line. Launching...